Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity
Effects of Whole-body Electromyostimulation and Dietary Supplements on Sarcopenic Obesity in Elderly Females Living in the Community
Sponsor: Bavarian Research Foundation, Munich, Germany
Listed as NCT02356016, this PHASE2/PHASE3 trial focuses on Sarcopenic Obesity and remains completed. Sponsored by Bavarian Research Foundation, Munich, Germany, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bavarian Research Foundation, Munich, Germany
- Physiomed, Laipersdorf, Germany
- Siemens AG
- University of Erlangen-Nürnberg
- University of Erlangen-Nürnberg Medical School
- miha bodytec, Gersthofen, Germany
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.